Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:375806.
doi: 10.5402/2012/375806. Epub 2012 Oct 17.

Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis

S Nouraei  1 , S Amir Ali Akbari, M Jorjani, H Alavi Majd, M Afrakhteh, A Ghafoorian, H Tafazzoli Harandi
Affiliations

Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis

S Nouraei et al. ISRN Obstet Gynecol. 2012.

Erratum in

Abstract

Background. According to the limited studies reporting new treatments for vulvovaginal candidiasis, this study was designed to compare the combination of fluconazole and oral protexin with fluconazole in the treatment of vulvovaginal candidiasis. Methods. A double-blind clinical trial was conducted, involving 90 women who were referred to the gynecology clinic. Vulvovaginal candidiasis was diagnosed with itching, cheesy vaginal discharge, and any one of the following: dysuria, pH < 4.5, dyspareunia, vulvar erythema, or vulvar edema and if branched hyphae and Candida buds were visible after addition of KOH 10% in the culture and the result of cultivation in Sabouraud's dextrose agar medium was positive. Patients were randomly classified into two groups Absence of discharge, itching, and negative culture results 5-7 days after completion of treatment indicated treatment success. Data in this study were analyzed using the SPSS version 17.0 software. Results. The combinations, fluconazole-oral protexin and fluconazole-placebo, were equally effective in reduction of complaints and symptoms, but fluconazole-oral protexin combination elicited a better therapeutic response (χ(2) = 6.7, P = 0.01). [corrected] In addition, fluconazole-oral protexin combination treatment demonstrated better recovery time (t = -2.04, P = 0.04). Conclusion. This study demonstrated that complementary treatment with probiotic Lactobacillus increased the efficacy of fluconazole in treatment of vulvovaginal candidiasis. Further research is recommended.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ryan KJ, Berkowitz RS, Barbieri RL, Dunaif A. Kistner's Gynecology and Women's Health. 7th edition. England, UK: Mosby; 1999.
    1. Berek JS, Novak E. Berek and Novak's Gynecology. Lippincott Williams & Wilkins; 2007.
    1. Gibbs RS, Danforth DN, Karlan BY, Haney AF. Danforth's Obstetrics and Gynecology. Lippincott Williams & Wilkins; 2008.
    1. Martinez RCR, Franceschini SA, Patta MC, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Letters in Applied Microbiology. 2009;48(3):269–274. - PubMed
    1. Ehrström S, Daroczy K, Rylander E, et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes and Infection. 2010;12(10):691–699. - PubMed

LinkOut - more resources

  NODES
INTERN 2
twitter 2